STACEY YEPES: Open Payments
NPI 1508147679 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 14 payments from 9 companies in 2025. Trend: 2023 $19 · 2024 $138 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $274 |
| Alnylam Pharmaceuticals Inc. | 5 | $123 |
| Medtronic, Inc. | 2 | $106 |
| Novartis Pharmaceuticals Corporation | 1 | $85 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| CVRx, Inc. | 1 | $13 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $8 |
Products named: Rapiblyk, ONPATTRO, Vanrafia, LINQ II, AMVUTTRA, ELIQUIS, SYMPLICITY G3, VERQUVO.
Industry payments across TX — which companies pay providers there.
